Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines

被引:5
作者
Kohler, Jillian C. [1 ,2 ,3 ]
Mackey, Tim K. [3 ,4 ,5 ,6 ,7 ]
机构
[1] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Univ Toronto, Leslie Dan Fac Pharm, Accountabil & Transparency Pharmaceut Sect & Prof, WHO Collaborating Ctr Governance, Toronto, ON, Canada
[4] Univ Calif San Diego, Sch Med, Dept Anesthesiol, San Diego, CA 92103 USA
[5] Univ Calif San Diego, Sch Med, Div Infect Dis & Global Publ Hlth, San Diego, CA 92103 USA
[6] Univ Calif San Diego, Dept Healthcare Res & Policy, San Diego, CA 92103 USA
[7] Global Hlth Policy Inst, San Diego, CA 91950 USA
关键词
Health policy; COVID-19; Access to medicines; Pharmaceutical policy; Pandemic response;
D O I
10.1186/s12916-020-01661-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 10 条
  • [1] [Anonymous], 2020, COVID 19 BEWARE FALS
  • [2] [Anonymous], 2017, ACC MED MAK MARK FOR
  • [3] [Anonymous], 2020, MED PROD AL
  • [4] Access to medicines from a health system perspective
    Bigdeli, Maryam
    Jacobs, Bart
    Tomson, Goran
    Laing, Richard
    Ghaffar, Abdul
    Dujardin, Bruno
    Van Damme, Wim
    [J]. HEALTH POLICY AND PLANNING, 2013, 28 (07) : 692 - 704
  • [5] Pathways to ensure universal and affordable access to hepatitis C treatment
    Douglass, Caitlin H.
    Pedrana, Alisa
    Lazarus, Jeffrey V.
    't Hoen, Ellen F. M.
    Hammad, Radi
    Leite, Ricardo Baptista
    Hill, Andrew
    Hellard, Margaret
    [J]. BMC MEDICINE, 2018, 16
  • [6] Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts
    Gleeson, Deborah
    Lexchin, Joel
    Labonte, Ronald
    Townsend, Belinda
    Gagnon, Marc-Andre
    Kohler, Jillian
    Forman, Lisa
    Shadlen, Kenneth C.
    [J]. GLOBALIZATION AND HEALTH, 2019, 15 (01)
  • [7] Goodman Peter S., 2020, N.Y. TIMES
  • [8] COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
    Newton, Paul N.
    Bond, Katherine C.
    [J]. LANCET GLOBAL HEALTH, 2020, 8 (06): : E754 - E755
  • [9] Piller Charles, 2020, SCIENCEMAG
  • [10] Driving a decade of change: HIV/AIDS, patents and access to medicines for all
    't Hoen, Ellen
    Berger, Jonathan
    Calmy, Alexandra
    Moon, Suerie
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2011, 14